Canada

Acerus Pharmaceuticals Corporation

Not featured in screeners

Not featured in screeners

Insider activity signals

0 activity signals detected for Acerus Pharmaceuticals Corporation

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Download results Settings

Herschkowitz, Samuel Director of Issuer Non-Executive Director

Transaction date 25 May 2022

Purchase

Price

324.12

Quantity 41,101 +18.0%

Value US$4,593,866

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-05-25	2022-05-25	B Purchase	Herschkowitz, Samuel Director of Issuer Non-Executive Director	41,101 +18.0% 324.12 US$4,593,866	41,101 +18.0%	324.12	US$4,593,866

More insider trading research around Acerus Pharmaceuticals Corporation